FEB 08, 2019 09:11 PM PST

Bodybuilding Supplement Harms Brain Cells

WRITTEN BY: Nouran Amin

Researchers at University of Technology Sydney warn that the protein supplement, L-norvaline, could damage brain cells. The study was published in Toxicology in Vitro describes how at low concentrations, L-norvaline induces unhealthy cells in the brain. The was the first reporting to investigate the toxicity of L-norvaline in human cells with a specific focus on the health of brain cells.

L-norvaline is a widely used bodybuilding supplement and promoted as a compound that can boost workouts and aid recovery. Naturally, our bodies use amino acids from our diet to make new proteins—however, L-norvaline is one of the amino acids that are not usually used by our physiological system to produce proteins.

Learn more about bodybuilding supplements:

"Protein requirements are higher in very active individuals and proteins are considered to improve and increase performance. The demand for amino acids in supplements has expanded but in addition to the normal protein-building amino acids other 'non-protein' amino acids are being taken," explains lead author, Kate Samardzic, a PhD candidate at UTS School of Life Sciences. "Some non-protein amino acids are toxic because they can mimic protein amino acids and deceive the body into making faulty proteins; a property used by some plants to kill predators.

Although it has been known that L-norvaline helps to produce more energy, it is now believed to damage the machinery used to generate that energy—producing long-term consequences for anyone who takes the supplement.

“Some plants can even release non-protein amino acids into the soil to kill other plants so that they can have access to all the nutrients. Chemical warfare among plants is a wellknown phenomenon. Since there was evidence that L-norvaline has an antimicrobial and herbicidal activity we examined its toxicity in human cells,” said Samardzic

Source: Science Daily

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 22, 2019
Drug Discovery & Development
OCT 22, 2019
Drug Targets Early Instigators of Alzheimer Disease
The two solidifying instigators of Alzheimer -disease (AD)—amyloid beta and the tau protein—have long been the topic of study for AD researcher...
OCT 22, 2019
Drug Discovery & Development
OCT 22, 2019
Comparison of Three Frontline Breast Cancer Drugs
Breast cancer affects 250,000 women in the U.S. annually. Those with most common form test positive for hormone receptors (HR+) and negative for the HER2 r...
OCT 22, 2019
Drug Discovery & Development
OCT 22, 2019
Drug Reduces Heart Attacks in Diabetic Patients
Recent results from a clinical trial that evaluated the addition of a drug called ‘ticagrelor’ to aspirin were shown to improve clinical outcom...
OCT 22, 2019
Immunology
OCT 22, 2019
A New Way To Fight Severe Peanut Allergies
Dr. Sandra Lin explains how SLIT is currently being used to treat allergies other than peanuts.    Over 1 million U.S. children have an allergy t...
OCT 22, 2019
Drug Discovery & Development
OCT 22, 2019
New Potential Early Stage Treatment for Parkinson's
Parkinson’s Disease is the second most common neurodegenerative condition, affecting 35 million people globally. Currently without a cure, researcher...
OCT 22, 2019
Cardiology
OCT 22, 2019
Heart Attacks Without The Risk
Following a heart attack, as the heart heals, scar tissue forms. This issue is less flexible than healthy heart tissue and may encumber the heart's abi...
Loading Comments...